跳至主要内容
临床试验/NCT07520279
NCT07520279Enrolling By Invitation不适用

Clinical Evaluation of the Xpert® Tropical Fever Test on the GeneXpert® Edge System Using Venous and Capillary Whole Blood Specimens

Cepheid1 个研究点 分布在 1 个国家目标入组 2,500 人开始时间: 2025年8月18日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
Cepheid
入组人数
2,500
试验地点
1
主要终点
Clinical performance [PPA and NPA] of Xpert Tropical Fever

研究概览

简要总结

This is a multi-site, observational, cross-sectional clinical study that includes geographically diverse sites within and outside the United States.

详细描述

Capillary and venous whole blood specimens will be prospectively collected from consented individuals who present with acute febrile illness and clinical suspicion of infection with fever-causing agents

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
14 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Presents with AFI as defined for endemic populations or fever as defined in non-endemic populations or presents with fever as defined for nonendemic populations
  • Clinical suspicion of disease caused by at least one of the following: Plasmodium spp, dengue virus, Zika virus, chikungunya virus, or Leptospira (endemic population)
  • History of residence in or travel to an endemic geographic region within 3 months prior to specimen collection (endemic population)

排除标准

  • Self-reported or known antibiotic or antimalarial use (oral or intravenous) within 3 days prior to enrollment (endemic and nonendemic population)
  • History of residence in or trael to endemic geographic region as defined by protocol ≤ three months prior to specimen collection (nonendemic population)
  • Clinical suspicion of infection caused by any of the following: Plasmodium spp., dengue virus, Zika virus, chikungunya virus, or Leptospira spp. (nonendemic population)

研究组 & 干预措施

Capillary and venous WB specimens

WB specimens collected from individuals who present with AFI and have clinical suspicion of infection caused by at least one fever-causing agent

干预措施: Xpert Tropical Fever test (Diagnostic Test)

结局指标

主要结局

Clinical performance [PPA and NPA] of Xpert Tropical Fever

时间窗: Clinical performance on specimens collected at Baseline (Day 0)

Evaluating the PPA and NPA of Xpert Tropical Fever relative to the comparator(s)

次要结局

未报告次要终点

研究者

发起方
Cepheid
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验